SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008858
Filing Date
2019-05-15
Accepted
2019-05-15 16:52:25
Documents
42
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_wizepharmainc.htm 10-Q 423318
2 CERTIFICATION f10q0319ex31-1_wizepharm.htm EX-31.1 7964
3 CERTIFICATION f10q0319ex31-2_wizepharm.htm EX-31.2 7954
4 CERTIFICATION f10q0319ex32-1_wizepharm.htm EX-32.1 5430
5 CERTIFICATION f10q0319ex32-2_wizepharm.htm EX-32.2 5650
  Complete submission text file 0001213900-19-008858.txt   2149650

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE wizp-20190331.xml EX-101.INS 318872
7 XBRL SCHEMA FILE wizp-20190331.xsd EX-101.SCH 34991
8 XBRL CALCULATION FILE wizp-20190331_cal.xml EX-101.CAL 34150
9 XBRL DEFINITION FILE wizp-20190331_def.xml EX-101.DEF 74177
10 XBRL LABEL FILE wizp-20190331_lab.xml EX-101.LAB 205362
11 XBRL PRESENTATION FILE wizp-20190331_pre.xml EX-101.PRE 140037
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 19829255
SIC: 2834 Pharmaceutical Preparations